Breath analysis for non-invasive clinical diagnostics and treatment progression has penetrated the research community owing to the technological developments in novel sensing nanomaterials.
The correlation between blood glucose and breath acetone suggested by several studies has spurred the research community to develop an electronic (e-nose) for diabetes diagnosis. Herein, we have validated the in-house graphene based sensors with known acetone concentration. The sensor performances such as sensitivity, selectivity and stability (SSS) suggested their potential use in acquiring breath print. The 10% higher mean saturation voltage for 30 diabetic subjects ensured a discrimination accuracy of 65% with a positive correlation ( r = 0.88) between biochemically measured and non-invasively estimated (glycated haemoglobin) HbA1c. For the improvement of classification rate, thirteen features associated with the adsorption kinetics were extracted from the breathprint from each of the three sensors. The features given as an input to the Naïve Bayes classification model fetched an accuracy of 68.33%. Elimination of redundant features by distinction index and one-R feature ranking algorithm results in Naïve Bayes algorithm with improved performances. The success rate has improved to 70% using the subset of features ranked by one-R algorithm. These results indicated the use of feature ranking algorithms and prediction models for the improvement in accuracy of our in-house fabricated graphene based sensors.
Several breath analysis studies have suggested a correlation between blood glucose (BG) levels and breath acetone, indicating acetone as a primary biomarker in exhaled breath for diabetes diagnosis. Herein, we have (i) fabricated and validated graphene-based chemi-resistive sensors for selective and sensitive detection of acetone, (ii) performed offline breath analysis by a static gas sensing set-up to acquire olfactory signals, and (iii) developed an LED-based portable on/off binary e-nose system for pre-screening diabetes through online analysis. The fabricated sensors showed selective detection for acetone with high sensitivity (5.66 for 1 ppm acetone vapor) and fast response and recovery times (10 s and 12 s) at low concentrations. The sensor responses of end tidal fractional breath (collected in Tedlar bags) in the fasting and postprandial conditions were compared with BG levels and glycated hemoglobin (HbA1c) levels taken at the same time in 30 volunteers (13 healthy and 17 diabetic subjects). The mean sensor responses of the diabetic subjects as obtained by offline analysis were 1.1 times higher than those of the healthy subjects. The optimal regression equation framed with the significant correlating variables for HbA1c estimation achieved an accuracy of 66.67%. The online breath analysis by on/off binary prototype exhibited an accuracy of 60.51%. Though there exists a minimal uncertainty in classification, the on/off type portable prototype is easy to operate, gives a quicker response with a refresh/recovery rate of 19 s and can be used for preliminary diagnosis, and can be used for preliminary diagnosis. This inexpensive sensor technology may revolutionize personalized medicine in the near future and greatly benefit the underprivileged.
Background: The scientific and clinical interest of breath analysis for non-invasive disease diagnosis has been focused by the scientific community over the past decade. This was due to the exhalation of prominent volatile organic compounds (VOCs) corresponding to the metabolic activities in the body and their concentration variation. To identify these biomarkers, various analytical techniques have been used in the past and the threshold concentration was established between a healthy and diseased state. Subsequently, various nanomaterials-based gas sensors were explored for their demand in quantifying these biomarkers for real-time, low cost and portable breathalyzers along with the essential sensor performances. Methods: We focus on the classification of graphene derivatives and their composites’ gas sensing efficiency for the application in the development of breathalyzers. The review begins with the feasibility of the application of nanomaterial gas sensors for healthcare applications. Then, we systematically report the gas sensing performance of various graphene derivatives/semiconductor metal oxides (SMO) binary nanocomposites and their optimizing strategies in selective detection of biomarkers specific to diseases. Finally, we provide insights on the challenges, opportunity and future research directions for the development of breathalyzers using other graphene derivatives/SMO binary nanocomposites. Results: On the basis of these analyses, graphene and its derivatives/metal oxides based binary nanocomposites have been a choice for gas sensing material owing to their high electrical conductivity and extraordinary thickness-dependent physicochemical properties. Moreover, the presence of oxygen vacancies in SMO does not only alter the conductivity but also accelerates the carrier transport rate and influence the adsorption behavior of target analyte on the sensing materials. Hence researchers are exploring the search of ultrathin graphene and metal oxide counterpart for high sensing performances. Conclusion: Their impressive properties compared to their bulk counterpart have been uncovered towards sensitive and selective detection of biomarkers for its use in portable breathalyzers.